{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T04:30:59Z","timestamp":1762144259663,"version":"3.30.2"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2004,1,15]]},"DOI":"10.1097\/01.tp.0000104844.48064.81","type":"journal-article","created":{"date-parts":[[2004,1,16]],"date-time":"2004-01-16T09:06:45Z","timestamp":1074244005000},"page":"55-60","source":"Crossref","is-referenced-by-count":30,"title":["The novel anti-inflammatory agent lisofylline prevents autoimmune diabetic recurrence after islet transplantation1"],"prefix":"10.1097","volume":"77","author":[{"given":"Zandong","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justin D.","family":"Ellett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lawrence B.","family":"Fialkow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey D.","family":"Carter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerry L.","family":"Nadler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-10-20210129","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0092-8674(00)81106-X","article-title":"Insulin dependent diabetes mellitus","volume":"85","author":"Tisch","year":"1996","journal-title":"Cell"},{"key":"R2-10-20210129","doi-asserted-by":"crossref","first-page":"613","DOI":"10.2337\/diab.43.5.613","article-title":"Immunoregulatory and cytokine imbalances in the pathogenesis of IDDM","volume":"43","author":"Rabinovitch","year":"1994","journal-title":"Diabetes"},{"key":"R3-10-20210129","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1007\/s00125-002-0901-y","article-title":"The anti-inflammatory compound lisofylline prevents type 1 diabetes in non-obese diabetic mice","volume":"45","author":"Yang","year":"2002","journal-title":"Diabetologia"},{"key":"R4-10-20210129","doi-asserted-by":"crossref","first-page":"570","DOI":"10.2337\/diabetes.47.4.570","article-title":"The phosphodiesterase inhibitors pentoxifylline and rolipram prevent diabetes in NOD mice","volume":"47","author":"Liang","year":"1998","journal-title":"Diabetes"},{"key":"R5-10-20210129","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1056\/NEJM200007273430401","article-title":"Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen","volume":"343","author":"Shapiro","year":"2000","journal-title":"N Engl J Med"},{"key":"R6-10-20210129","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1097\/00007890-199604270-00027","article-title":"Evidence of recurrent autoimmunity in human allogeneic islet transplantation","volume":"61","author":"Stegall","year":"1996","journal-title":"Transplantation"},{"key":"R7-10-20210129","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2337\/diab.41.1.53","article-title":"Characterization of T lymphocytes infiltrating human pancreas allograft affected by isletitis and recurrent diabetes","volume":"41","author":"Santamaria","year":"1992","journal-title":"Diabetes"},{"key":"R8-10-20210129","doi-asserted-by":"crossref","first-page":"6567","DOI":"10.4049\/jimmunol.163.12.6567","article-title":"Selective pharmacologic inhibition of murine and human IL-12-dependent Th1 differentiation and IL-12 signaling","volume":"163","author":"Coon","year":"199","journal-title":"J Immunol"},{"key":"R9-10-20210129","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/00024382-199404000-00003","article-title":"CT-1501R selectively inhibits induced inflammatory monokines in human whole blood ex vivo","volume":"1","author":"Rice","year":"1994","journal-title":"Shock"},{"key":"R10-10-20210129","doi-asserted-by":"crossref","first-page":"7015","DOI":"10.4049\/jimmunol.161.12.7015","article-title":"Prevention of experimental allergic encephalomyelitis via inhibition of IL-12 signaling and IL-12-mediated Th1 differentiation: An effect of the novel anti-inflammatory drug lisofylline","volume":"161","author":"Bight","year":"1998","journal-title":"J Immunol"},{"key":"R11-10-20210129","doi-asserted-by":"crossref","first-page":"4871","DOI":"10.1210\/endo.137.11.8895359","article-title":"Lisofylline, an inhibitor of unsaturated phosphatidic acid generation, ameliorates interleukin-1\u03b2\u2013induced dysfunction in cultured rat islets","volume":"137","author":"Bleich","year":"1996","journal-title":"Endocrinology"},{"key":"R12-10-20210129","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1210\/endo.143.6.8841","article-title":"Lisofylline, a novel antiinflammatory agent, protects pancreatic \u03b2-cells from proinflammatory cytokine damage by promoting mitochondrial metabolism","volume":"143","author":"Chen","year":"2002","journal-title":"Endocrinology"},{"key":"R13-10-20210129","first-page":"215","article-title":"Roles of cytokines in IDDM pathogenesis and islet \u03b2-cell destruction","volume":"1","author":"Rabinovitch","year":"1993","journal-title":"Diabetes Rev"},{"key":"R14-10-20210129","first-page":"132","article-title":"Recurrent diabetes mellitus in the pancreas iso- and allograft","volume":"53","author":"Sibley","year":"1985","journal-title":"Lab Invest"},{"key":"R15-10-20210129","doi-asserted-by":"crossref","first-page":"519","DOI":"10.3727\/000000002783985503","article-title":"Gene transfection and expression of transforming growth factor-beta 1 in nonobese diabetic mouse islets protects beta-cells in syngeneic islet grafts from autoimmune destruction","volume":"11","author":"Suarez-Pinzon","year":"2002","journal-title":"Cell Transplant"},{"key":"R16-10-20210129","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1097\/00007890-199805150-00014","article-title":"Prevention of autoimmune destruction of syngeneic islet grafts in spontaneously diabetic nonobese diabetic mice by a combination of a vitamin D3 analog and cyclosporine","volume":"65","author":"Casteels","year":"1998","journal-title":"Transplantation"},{"key":"R17-10-20210129","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1007\/s00125-001-0745-x","article-title":"Combination therapy with low dose sirolimus and tacrolimus is synergistic in preventing spontaneous and recurrent autoimmune diabetes in non-obese diabetic mice","volume":"45","author":"Shapiro","year":"2002","journal-title":"Diabetologia"},{"key":"R18-10-20210129","doi-asserted-by":"crossref","first-page":"652","DOI":"10.2337\/diabetes.48.3.652","article-title":"Prevention of autoimmune recurrence and rejection by adenovirus mediated CTLA4Ig gene transfer to the pancreatic graft in BB rat","volume":"48","author":"Uchikoshi","year":"1999","journal-title":"Diabetes"},{"key":"R19-10-20210129","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s001250100519","article-title":"MFP14, a multifunctional emerging protein with immunomodulation properties, prevents spontaneous and recurrence autoimmune diabetes in NOD mice","volume":"44","author":"Panerai","year":"2001","journal-title":"Diabetologia"},{"key":"R20-10-20210129","doi-asserted-by":"crossref","first-page":"3857","DOI":"10.1073\/pnas.91.9.3857","article-title":"Protection from endotoxic shock in mice by pharmacologic inhibitor of phosphatidic acid","volume":"91","author":"Rice","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"R21-10-20210129","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S0041-1345(98)01561-9","article-title":"Translocation of bacteria from the gastrointestinal tract: Protection afforded by lisofylline","volume":"31","author":"Cicalese","year":"1999","journal-title":"Transplant Proc"},{"key":"R22-10-20210129","first-page":"14","article-title":"Potential role for phosphatidic acid in mediating the inflammatory responses to TNF alpha and IL-1 beta","volume":"44","author":"Bursten","year":"1994","journal-title":"Circ Shock"},{"key":"R23-10-20210129","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/sj.bmt.1702114","article-title":"A randomized placebo-controlled trial of lisofylline in HLA-identical, sibling-donor, allogeneic bone marrow transplant recipients","volume":"25","author":"List","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"R24-10-20210129","doi-asserted-by":"crossref","first-page":"E99","DOI":"10.1097\/00006676-200305000-00021","article-title":"The novel anti-inflammatory compound, lisofylline, prevents diabetes in multiple-low dose streptozocin-treated mice","volume":"26","author":"Yang","year":"2003","journal-title":"Pancreas"},{"key":"R25-10-20210129","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1006\/jsre.1998.5453","article-title":"Selective downregulation of neutrophils by a phosphatidic acid generation inhibitor in a porcine sepsis model","volume":"81","author":"Oka","year":"1999","journal-title":"J Surg Res"},{"key":"R26-10-20210129","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/382174a0","article-title":"Impaired IL-12 responses and enhanced development of Th2 cells in STAT4-deficient mice","volume":"382","author":"Kaplan","year":"1996","journal-title":"Nature"},{"key":"R27-10-20210129","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/382171a0","article-title":"Requirement for STAT4 in interleukin-12-mediated responses of natural killer and T cells","volume":"382","author":"Thierfelder","year":"1996","journal-title":"Nature"},{"key":"R28-10-20210129","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1002\/eji.1830270930","article-title":"Deviation of pancreas-infiltrating cells to Th2 by interleukin-12 antagonist administration inhibits autoimmune diabetes","volume":"27","author":"Trembleau","year":"1997","journal-title":"Eur J Immunol"},{"key":"R29-10-20210129","first-page":"31","article-title":"Inhibition of STAT4 activation by lisofylline is associated with the protection of autoimmune diabetes","volume":"18","author":"Yang","year":"2002","journal-title":"Diabetes Metab Res Rev"},{"key":"R30-10-20210129","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/nm804","article-title":"Interleukin-4 therapy of psoriasis induces Th2 responses and improves human autoimmune disease","volume":"9","author":"Ghoreschi","year":"2003","journal-title":"Nat Med"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/01.TP.0000104844.48064.81","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,14]],"date-time":"2024-12-14T23:00:36Z","timestamp":1734217236000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007890-200401150-00010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,1,15]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004]]}},"URL":"https:\/\/doi.org\/10.1097\/01.tp.0000104844.48064.81","relation":{},"ISSN":["0041-1337"],"issn-type":[{"type":"print","value":"0041-1337"}],"subject":[],"published":{"date-parts":[[2004,1,15]]}}}